The stock of CMS Energy Corporation (NYSE:CMS) close at $45.81 and maintained the same position in yesterday’s trading session.MS Energy Corporation’s CMS subsidiary Consumers Energy has made an announcement revealing it has finally succeeded at bringing online its renewable project. Cross Winds Energy Park II is at the moment making a contribution of about 44 megawatts (MW) in terms of the renewable energy and almost 17,000 residents in Michigan are getting to benefit as a result.
A person familiar with the matter said, “Consumers Energy invested $90 million in the Phase II of Cross Winds Energy Park to construct 19 turbines, each of which is 499 feet tall. The phase I of Cross Winds project began its operations in 2014, and is capable of producing 155 MW of renewable energy, sufficient to serve about 60,000 residents.”
The question that quite a significant number of people are asking is whether or not CMS Energy will have something to benefit from the deal. If everything goes according to plan, it is projected that the Phase II of the project will help the company achieve its goal of making a contribution of about $5 billion toward the state economy and that will be within a timeframe of about five years.
Fundamentally, the Cross Winds Energy Park Phase II project is part and parcel of a $345 million deal which is constituted by about 81 wind turbines. Consumers Energy has much to gain from the aforementioned project considering it will be able to live up to its commitment of serving the wide array of need which have been growing overtime.
The large businesses that have been looking forward to going 100% renewable have been catered for. Business dynamics are taking over the world and each and every business is looking for the various ways to employ towards gaining more competitive edge.
CMS Energy has directed pretty much in the current times towards the expansion of its renewable portfolio, a matter that has been applauded by several market analysts. The company is on track towards achieving immense business success.